Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Wallich

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
Zeitschrift Fur Orthopadie Und Ihre Grenzgebiete|March 9, 2007
[Differential behaviour of human adult arthrotic chondrocytes under 2D- and 3D-cultivation set-ups in a collagen I gel]M Niethard, U Schneider, R Wallich
Journal of Clinical Microbiology|June 5, 2001
Recombinant low-molecular-mass proteins pG and LA7 from Borrelia burgdorferi reveal low diagnostic sensitivity in an enzyme-linked immunosorbent assayS Rauer, R Wallich, U Neubert
Viral Immunology|March 29, 2001
Virulence of mousepox virus is independent of serpin-mediated control of cellular cytotoxicityR Wallich, M M Simon, A Müllbacher
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1982
Analysis of T15 idiotopes by monoclonal antibodies: variability of idiotopic expression on phosphorylcholine-specific lymphocytes from individual inbred miceJ Cerny, R Wallich, G J Hammerling
The Journal of Experimental Medicine|August 1, 1982
Elicitation of delayed-type hypersensitivity to phosphorylcholine by monoclonal anti-idiotypic antibodies in an allogeneic environmentB Arnold, R Wallich, G J Hämmerling
Infection|September 1, 1996
The recombinant outer surface protein A (lipOspA) of Borrelia burgdorferi: a Lyme disease vaccineR Wallich, M D Kramer, M M Simon
Infection|March 1, 1996
The outer surface protein A (OspA) of Borrelia burgdorferi: a vaccine candidate and bioactive mediatorM D Kramer, R Wallich, M M Simon
International Immunology|December 1, 1991
Dual function of recombinant human CD58: inhibition of T cell adhesion and activation via the CD2 pathwayM Albert-Wolf, S C Meuer, R Wallich
Developments in Biological Standardization|January 1, 1992
Immunomodulatory properties of soluble recombinant human CD58 (LFA-3) moleculesM Albert-Wolf, S C Meuer, R Wallich
Behring Institute Mitteilungen|December 1, 1994
A recombinant vaccine for Lyme diseaseR Wallich, M D Kramer, M M Simon
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
Zeitschrift Fur Orthopadie Und Ihre Grenzgebiete|March 9, 2007
[Differential behaviour of human adult arthrotic chondrocytes under 2D- and 3D-cultivation set-ups in a collagen I gel]M Niethard, U Schneider, R Wallich
Journal of Clinical Microbiology|June 5, 2001
Recombinant low-molecular-mass proteins pG and LA7 from Borrelia burgdorferi reveal low diagnostic sensitivity in an enzyme-linked immunosorbent assayS Rauer, R Wallich, U Neubert
Viral Immunology|March 29, 2001
Virulence of mousepox virus is independent of serpin-mediated control of cellular cytotoxicityR Wallich, M M Simon, A Müllbacher
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1982
Analysis of T15 idiotopes by monoclonal antibodies: variability of idiotopic expression on phosphorylcholine-specific lymphocytes from individual inbred miceJ Cerny, R Wallich, G J Hammerling
The Journal of Experimental Medicine|August 1, 1982
Elicitation of delayed-type hypersensitivity to phosphorylcholine by monoclonal anti-idiotypic antibodies in an allogeneic environmentB Arnold, R Wallich, G J Hämmerling
Infection|September 1, 1996
The recombinant outer surface protein A (lipOspA) of Borrelia burgdorferi: a Lyme disease vaccineR Wallich, M D Kramer, M M Simon
Infection|March 1, 1996
The outer surface protein A (OspA) of Borrelia burgdorferi: a vaccine candidate and bioactive mediatorM D Kramer, R Wallich, M M Simon
International Immunology|December 1, 1991
Dual function of recombinant human CD58: inhibition of T cell adhesion and activation via the CD2 pathwayM Albert-Wolf, S C Meuer, R Wallich
Developments in Biological Standardization|January 1, 1992
Immunomodulatory properties of soluble recombinant human CD58 (LFA-3) moleculesM Albert-Wolf, S C Meuer, R Wallich
Behring Institute Mitteilungen|December 1, 1994
A recombinant vaccine for Lyme diseaseR Wallich, M D Kramer, M M Simon
Pageof 9